Bubeník J, Símová J
Folia Biol (Praha). 1982;28(4):274-9.
Tumorigenicity of two thymic lymphoma cell lines BW5147 (H-2k/H-2k; HGPRT-) and EL-4R (H-2b/H-2b; TK-) was compared with that of their hybrid cell line BH2 (H-2k/H-2k x H-2b/H-2b; HGPRT+; TK+). Tumour inocula from the parental and hybrid cell lines grew in syngeneic but not allogeneic recipients; the possible admixture of the revertant parental cells (BW5147HGPRT+, EL-4RTK+) in the hybrid cell population was, according to the transplantation tests, lower than 10(-4). The tumorigenicity of the hybrid cell line BH2 in the (B10 X AKR)F1 hybrid recipients was substantially lower than the tumorigenicity of the parental cell lines in both semisyngeneic (B10 X AKR)F1 and syngeneic mice.
将两种胸腺淋巴瘤细胞系BW5147(H-2k/H-2k;次黄嘌呤-鸟嘌呤磷酸核糖转移酶缺陷型)和EL-4R(H-2b/H-2b;胸苷激酶缺陷型)的致瘤性与其杂交细胞系BH2(H-2k/H-2k×H-2b/H-2b;HGPRT+;TK+)的致瘤性进行了比较。来自亲代细胞系和杂交细胞系的肿瘤接种物在同基因受体中生长,但在异基因受体中不生长;根据移植试验,杂交细胞群体中回复亲代细胞(BW5147HGPRT+,EL-4RTK+)的可能混合比例低于10^(-4)。杂交细胞系BH2在(B10×AKR)F1杂交受体中的致瘤性明显低于亲代细胞系在半同基因(B10×AKR)F1和同基因小鼠中的致瘤性。